Fig. 1. Number of applications received versus awards offered by the Foundation for Women's Cancer between 1995 and 2007. The last four decades have witnessed remarkable advances in gynecologic cancer care and research. The year 2011 is an important year in gynecologic oncology since it marks the 20th anniversary of the Foundation for Women's Cancer (previously known as Gynecologic Cancer Found...

Abstract Gynecologic oncology is considered a new field, but its roots are buried deep in the past. As with other tumors, earliest progress modern times started anesthesia and surgery. This was followed by landmark achievements pathology, cytology, radiotherapy, chemotherapy, tumor virology, generation of high-quality evidence, and, more recently, genetics genomics. Some most notable progresses...

BACKGROUND Continuing symptoms and poor health following cancer treatments may alter meaning in life for cancer survivors. Gynecologic cancer survivors are particularly troubled with physical sequelae. In addition, for the most common sites of disease, such as breast and gynecologic cancers, the prevalence of depression is also high. PURPOSE This study tests meaning in life as a mechanism for...

Cervical, endometrial, and ovarian cancers, have both high morbidity and mortality among the gynecologic malignant tumors in Japan. The present study was conducted using both the population-based cancer registry and the gynecologic cancer registry to elucidate the characteristics of gynecologic malignant tumors in Japan. Based on nationwide estimates from the population-based cancer registry in...

The use of complementary and alternative medicines (CAM) among women with gynecologic cancer is becoming increasingly popular. Therefore, it is important to gain insight into the prevalence and factors related to the use of CAM. The aim of this study was to assess the use of CAM in women with gynecologic cancer. This is a descriptive cross-sectional study. Data were obtained from 67 gynecologic...